ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2018 Pharmaceutical Investing
Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa Biotech Investing
GGB Beauty LLC Signs a Long Term Licensing Partnership with Authentic Brands Group and Greg Norman Cannabis Investing News
Novelion Therapeutics Subsidiary Enters Into Licensing Agreement for JUXTAPID® in Japan Biotech Investing
Catalyst Biosciences Announces Preclinical Proof-of-Concept Data of Gene Therapy Candidate Biotech Investing
Corvus Presents Updated Biomarker and Clinical Results from Lead Pipeline Programs Pharmaceutical Investing
Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia Biotech Investing
